Literature DB >> 28480521

The Client Satisfaction Questionnaire-8: Psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment.

Peter J Kelly1, Felicity Kyngdon1, Isabella Ingram1, Frank P Deane1, Amanda L Baker2, Briony A Osborne1.   

Abstract

INTRODUCTION AND AIMS: The Client Satisfaction Questionnaire (CSQ-8) is one of a limited number of standardised satisfaction measures that have been used widely across mental health services. This study examined the CSQ-8 as a measure of general satisfaction within residential substance abuse treatment. It compared the CSQ-8 with another established measure of client satisfaction that was developed for substance abuse treatment settings (Treatment Perceptions Questionnaire, TPQ). It also sought to examine the relationship between the CSQ-8 and commonly used process measures. DESIGN AND METHODS: Cross-sectional data was collected from across 14 Australian residential medium-to-long term alcohol and other drug treatment facilities (N = 1378). Demographic, substance abuse and mental health characteristics were collected, as well as process measures of craving, general functioning, self-perceptions, recovery and symptom distress.
RESULTS: A confirmatory factory analysis established that the CSQ-8 retains a single factor. The scale was strongly correlated with the TPQ, suggesting high concurrent validity. However, while the TPQ was normally distributed, the CSQ-8 was highly negatively skewed. Significant associations were found between the CSQ-8 and cross-sectional process measures. DISCUSSION AND
CONCLUSIONS: Results suggest that that CSQ-8 is an appropriate measure to be used in residential substance abuse treatment settings. However, because of the high levels of negative skew, it is likely that the TPQ is more accurate in capturing clients' dissatisfaction than the CSQ-8. Future research should include longitudinal studies of satisfaction in order to examine how changes in satisfaction may be related to client characteristics, outcome measures, dropout or re-engagement in treatment. [Kelly PJ, Kyngdon F, Ingram I, Deane FP, Baker AL, Osborne BA. The Client Satisfaction Questionnaire-8: Psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment. Drug Alcohol Rev 2018;37:79-86].
© 2017 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  alcohol and substance abuse; client satisfaction; quality improvement; residential rehabilitation; therapeutic community; treatment experience

Mesh:

Year:  2017        PMID: 28480521     DOI: 10.1111/dar.12522

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  23 in total

1.  An integrated videoconferencing intervention for chronic pain and heavy drinking among patients in HIV-care: a proof-of-concept study.

Authors:  Tibor P Palfai; Richard Saitz; Maya P L Kratzer; Jessica L Taylor; John D Otis; Judith A Bernstein
Journal:  AIDS Care       Date:  2020-06-11

2.  Adaptations and patient responses to behavioral intervention components in a depression-focused chronic disease care model implemented in India.

Authors:  Leslie C M Johnson; Lydia Chwastiak; Subramani Poongothai; Nikhil Tandon; Ranjit Mohan Anjana; Sosale Aravind; Gumpeny Ramachandra Sridhar; Deepa Rao; Viswanathan Mohan; Mohammed K Ali
Journal:  Transl Behav Med       Date:  2020-02-03       Impact factor: 3.046

3.  Cognitive behavioral therapy for insomnia among young adults who are actively drinking: a randomized pilot trial.

Authors:  Mary Beth Miller; Chelsea B Deroche; Lindsey K Freeman; Chan Jeong Park; Nicole A Hall; Pradeep K Sahota; Christina S McCrae
Journal:  Sleep       Date:  2021-02-12       Impact factor: 6.313

4.  Computer-aided learning for managing stress: A feasibility trial with clinical high risk adolescents and young adults.

Authors:  Kristen A Woodberry; Cole Chokran; Kelsey A Johnson; Keith H Nuechterlein; David J Miklowitz; Stephen V Faraone; Larry J Seidman
Journal:  Early Interv Psychiatry       Date:  2020-04-01       Impact factor: 2.721

5.  Factors predicting satisfaction in outpatient substance abuse treatment: a prospective follow-up study.

Authors:  Katja Kuusisto; Tomi Lintonen
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-05-24

6.  Developing and evaluating ASTHMAXcel adventures: A novel gamified mobile application for pediatric patients with asthma.

Authors:  Brian C Hsia; Anjani K Singh; Obumneme Njeze; Emine Cosar; Wenzhu B Mowrey; Jonathan Feldman; Marina Reznik; Sunit P Jariwala
Journal:  Ann Allergy Asthma Immunol       Date:  2020-07-22       Impact factor: 6.347

7.  Using the Multiphase Optimization Strategy (MOST) framework to test intervention delivery strategies: a study protocol.

Authors:  Sarabeth Broder-Fingert; Jocelyn Kuhn; Radley Christopher Sheldrick; Andrea Chu; Lisa Fortuna; Megan Jordan; Dana Rubin; Emily Feinberg
Journal:  Trials       Date:  2019-12-16       Impact factor: 2.279

8.  The Efficacy, Feasibility And Acceptability Of A Remotely Accessible Use Of CIRCuiTS, A Computerized Cognitive Remediation Therapy Program For Schizophrenia: A Pilot Study.

Authors:  Davide Palumbo; Armida Mucci; Giulia Maria Giordano; Giuseppe Piegari; Carmen Aiello; Daria Pietrafesa; Nicola Annarumma; Marcello Chieffi; Matteo Cella; Silvana Galderisi
Journal:  Neuropsychiatr Dis Treat       Date:  2019-11-08       Impact factor: 2.570

9.  Scleroderma Patient-centered Intervention Network-Scleroderma Support group Leader EDucation (SPIN-SSLED) program: non-randomised feasibility trial.

Authors:  Brett D Thombs; Laura Dyas; Mia Pépin; Kylene Aguila; Marie-Eve Carrier; Lydia Tao; Sami Harb; Vanessa L Malcarne; Ghassan El-Baalbaki; Sandra Peláez; Maureen Sauve; Marie Hudson; Robert W Platt
Journal:  BMJ Open       Date:  2019-11-11       Impact factor: 2.692

10.  Patient satisfaction and associated factors among psychiatry outpatients of St Paulo's Hospital, Ethiopia.

Authors:  Kebebew Wogi Goben; Endalamaw Salelew Abegaz; Samuel Tolesa Abdi
Journal:  Gen Psychiatr       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.